Advertisement

Topics

Bonti Announces Poster Presentation on EB-001 Pharmacological Profile at Abdominal Wall Reconstruction Conference

08:30 EDT 6 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Lead Product Candidate, A Botulinum Neurotoxin Serotype E (BoNT/E), To Be Featured on June 8th in Washington, DC Bonti, a privately-held, clinical-stage biotechnology company, today announced a poster presentation highlighti...

Other Sources for this Article

Bonti
Orlando Rodrigues, 760-212-5727
Media Relations
orlando@bonti.com

NEXT ARTICLE

More From BioPortfolio on "Bonti Announces Poster Presentation on EB-001 Pharmacological Profile at Abdominal Wall Reconstruction Conference"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...